abstract

• Women experience two to three times the rate of depression that men do. Selective serotonin reuptake inhibitors (SSRIs) are prescribed for many conditions other than depression, such as anxiety disorders, premenstrual dysphoric disorder, pain syndromes, impulse control disorders, and personality disorders, some of which are more common in women. Increasing awareness of sexual side effects has tempered the initial enthusiasm with which SSRIs were greeted. Men taking SSRIs report higher rates of sexual side effects than women taking them, however, women seem to experience more severe sexual dysfunction. In this article, we discuss the epidemiology of sexual dysfunction and describe treatments with sildenafil.

authors

• Paula Hensley, MD
• George Nurnberg, MD

publication date

• January 1, 2002

published in

• Journal of sex & marital therapy  Journal

keywords

• Adult
• Depressive Disorder, Major
• Female
• Humans
• Piperazines
• Purines
• Serotonin Uptake Inhibitors
• Sexual Dysfunctions, Psychological
• Sulfones
• Vasodilator Agents

Digital Object Identifier (DOI)

• https://doi.org/10.1080/00926230252851267

PubMed ID

• 11898696

start page

• 143

end page

• 153

volume

• 28 Suppl 1

number